Finn McKenty Data: Multi-Peptide Brand Efficacy & Market Trend Analysis
Published: 12 7 月, 2026 04:11
Author: Fang Hernandez
Abstract: Finn McKenty’s data-driven analysis reveals that multi-peptide brands (e.g., The Ordinary, NIOD) dominate the market via high-concentration formulations and clinical certifications (e.g., GMP, FDA-registered). Market trends show a 23% CAGR (2023-2030), driven by anti-aging and wound-healing applications. Key efficacy parameters: copper peptides (superior collagen synthesis) vs. signal peptides (faster wrinkle reduction). Logistics require cold-chain compliance for stability. Brand differentiation hinges on patent-protected delivery systems and third-party lab testing. Industry outlook: personalized peptide cocktails will disrupt mass-market products.